4//SEC Filing
Shepard Kirk V. 4
Accession 0001140361-24-003434
CIK 0001472091other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 4:33 PM ET
Size
5.5 KB
Accession
0001140361-24-003434
Insider Transaction Report
Form 4
Shepard Kirk V.
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2024-01-22+200,000→ 200,000 totalExercise: $4.49Exp: 2034-01-22→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended. The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 22,2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Documents
Issuer
PDS Biotechnology Corp
CIK 0001472091
Entity typeother
Related Parties
1- filerCIK 0002009007
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 4:33 PM ET
- Size
- 5.5 KB